American Well Corporation reported third quarter 2025 subscription revenue of $30.9 million and Amwell Medical Group visit revenue of $21.2 million. The company achieved a gross margin of 52.4%. Net loss was $31.9 million, compared to a net loss of $19.5 million in the previous quarter. Adjusted EBITDA was negative $12.7 million, compared to negative $4.7 million in the second quarter. Total visits reached 1.1 million. For full-year 2025, Amwell updated its revenue guidance to a range of $245 million to $248 million and narrowed its Adjusted EBITDA guidance to negative $45 million to negative $42 million. The company expects Amwell Medical Group visits between 1.3 million and 1.35 million. For the fourth quarter, revenue is expected to be between $51 million and $54 million, with Adjusted EBITDA between negative $15 million and negative $12 million. Amwell reiterated its objective to achieve positive cash flow from operations in 2026.